These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 11117982)
1. The FDA, regulation, and the risk of stroke. Fleming GA N Engl J Med; 2000 Dec; 343(25):1886-7. PubMed ID: 11117982 [No Abstract] [Full Text] [Related]
2. Phenylpropanolamine and hemorrhagic stroke. Ernst ME; Hartz A N Engl J Med; 2001 Apr; 344(14):1094; author reply 1095. PubMed ID: 11291667 [No Abstract] [Full Text] [Related]
3. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. Haller CA; Benowitz NL N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974 [TBL] [Abstract][Full Text] [Related]
4. Phenylpropanolamine and hemorrhagic stroke in the Hemorrhagic Stroke Project: a reappraisal in the context of science, the Food and Drug Administration, and the law. Stier BG; Hennekens CH Ann Epidemiol; 2006 Jan; 16(1):49-52. PubMed ID: 16216529 [TBL] [Abstract][Full Text] [Related]
5. FDA issues public health advisory on phenylpropanolamine in drug products. Meadows M FDA Consum; 2001; 35(1):9. PubMed ID: 11930934 [No Abstract] [Full Text] [Related]
6. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications. Mersfelder TL Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849 [TBL] [Abstract][Full Text] [Related]
8. [Stroke and phenylpropanolamine: what risk factors and what recommendations in request?]. Die-Kacou H; Kamagaté M; Daubrey-Potey TH; Bamba-Kamagaté D; Yavo JC; Balayssac E; Gboignon VM; Kakou KA; Gilbernaire AF Dakar Med; 2007; 52(1):56-7. PubMed ID: 19102094 [No Abstract] [Full Text] [Related]
9. Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America. Figueras A; Laporte JR Drug Saf; 2002; 25(10):689-93. PubMed ID: 12167064 [TBL] [Abstract][Full Text] [Related]
10. Regarding "Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project": mercenary epidemiology--data reanalysis and reinterpretation for sponsors with financial interest in the outcome. Michaels D Ann Epidemiol; 2006 Jul; 16(7):583-5; author reply 586. PubMed ID: 16814150 [No Abstract] [Full Text] [Related]
11. Diet drugs: what a pill. Banned but unbowed. Brink S US News World Rep; 2000 Nov; 129(20):74. PubMed ID: 11186829 [No Abstract] [Full Text] [Related]
12. Medicine. Ephedra--scientific evidence versus money/politics. Wolfe SM Science; 2003 Apr; 300(5618):437. PubMed ID: 12702860 [No Abstract] [Full Text] [Related]
13. The need for regulation of dietary supplements--lessons from ephedra. Fontanarosa PB; Rennie D; DeAngelis CD JAMA; 2003 Mar; 289(12):1568-70. PubMed ID: 12672775 [No Abstract] [Full Text] [Related]
14. Regarding "phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project". Clapp R; Williams ML Ann Epidemiol; 2006 Jul; 16(7):580-2; author reply 586. PubMed ID: 16814149 [No Abstract] [Full Text] [Related]
15. Underreporting of hemorrhagic stroke associated with phenylpropanolamine. La Grenade L; Graham DJ; Nourjah P JAMA; 2001 Dec; 286(24):3081. PubMed ID: 11754672 [No Abstract] [Full Text] [Related]
16. Phenylpropanolamine contained in cold remedies and risk of hemorrhagic stroke. Domingue JN Neurology; 2007 Jul; 69(3):320; author reply 320-1. PubMed ID: 17636076 [No Abstract] [Full Text] [Related]
17. Use of herbal products and symptoms of bipolar disorder. Emmanuel NP; Jones C; Lydiard RB Am J Psychiatry; 1998 Nov; 155(11):1627. PubMed ID: 9812133 [No Abstract] [Full Text] [Related]